Best ARA-290 For Sale

$95.00

ARA-290 is a synthetic peptide compound studied in laboratory and scientific research environments for its interactions with cellular signaling and physiological response pathways. It has generated interest within peptide science because of its potential involvement in tissue-response and inflammation-related mechanisms.

Description

Best ARA-290 For Sale | What is ARA-290? | Tissue and Cellular Signaling Studies

Best ARA-290 For Sale. ARA-290, also known as cibinetide or pHBSP (pyroglutamate helix B surface peptide), is an 11–amino acid peptide derived from the helix B region of erythropoietin (EPO). Unlike EPO, ARA-290 does not stimulate red blood cell production, focusing instead on tissue protection, anti-inflammation, and repair. Shop premium ARA-290 16mg at Peptide Online Store

Advances in peptide and cellular research continue increasing scientific interest in compounds associated with signaling pathways and physiological regulation. ARA-290 remains a topic of discussion in peptide-focused laboratory research involving tissue-response and cellular communication mechanisms. Buy 99% pure ARA-290 peptide (12mg) online

buy ara 290 online
Best ARA-290 For Sale

Mechanism of Action

  • Innate Repair Receptor (IRR): ARA-290 selectively targets the IRR, a heteromeric complex composed of the erythropoietin receptor and the β-common (CD131) subunit. Activation of IRR triggers anti-inflammatory and tissue-repair pathways

  • TRPV1 Modulation: It also antagonizes TRPV1 (capsaicin receptor), which plays a key role in nociceptive pain signaling. This mechanism contributes to its analgesic (pain-relief) effects. Buy ARA-290 Peptide Turkey in Vials, Nasals and Pre-Mixed Pens


Therapeutic Potential & Research Highlights

1. Small-Fiber Neuropathy (Sarcoidosis-Associated)

  • In controlled trials, 28 days of subcutaneous ARA-290 markedly improved neuropathic symptoms and autonomic dysfunction in sarcoidosis patients.

  • It also promoted regeneration of small nerve fibers in the cornea and enhanced exercise capacity (6-minute walk test)

2. Type 2 Diabetes with Neuropathy

  • In phase II studies, daily ARA-290 improved glycemic control (reduced HbA₁c), lipid profiles, neuropathic pain, and increased corneal nerve fiber density — without safety concerns

3. Anti-Inflammatory & Tissue-Protective Actions

  • Preclinical findings demonstrate that ARA-290 inhibits pro-inflammatory cytokines (e.g., TNF-α) and reduces apoptosis through IRR engagement. It accelerates wound healing, reduces scarring, and supports recovery across tissues. Buy ARA-290 Pre-Mixed Pen UK.

4. Neuropathic Pain Models

  • In animal models of sciatic nerve injury and neuropathic pain, ARA-290 reduces mechanical allodynia and cold sensitivity, demonstrating rapid and sustained relief. This effect is absent in animals lacking the β-common receptor, underscoring IRR’s role. Buy ARA290 peptide vial available in 2mg

  • A recent mouse study found that ARA-290 alleviates chronic stress-induced depression-like behavior. It appears to modulate the immune system and microglial activation, acting similarly to classical antidepressants but via distinct inflammatory pathways. ARA-290 peptide research

  • A still more recent report reaffirms ARA-290’s continuing promise in reducing neuropathic pain and inflammation through mechanisms akin to those of EPO — without hematopoietic side effects. Buy research-grade ARA-290


Summary Table

Key Features Details
Origin 11-amino acid peptide derived from EPO (non-erythropoietic)
Mechanisms Activates IRR (tissue-protective), antagonizes TRPV1
Therapeutic Effects Relief from neuropathic pain, improved nerve regeneration, metabolic benefits, anti-inflammation
Clinical Status Phase II/III trials in neuropathy; orphan drug status for sarcoid neuropathy
Safety Profile Favorable so far — minimal side effects reported in trials

Additional information

MG

10mg*10vials

Cat. No

RA10

Reviews

There are no reviews yet.

Be the first to review “Best ARA-290 For Sale”

Your email address will not be published. Required fields are marked *